等待开盘 09-20 09:30:00 美东时间
+0.021
+0.08%
Galapagos (NASDAQ:GLPG) said it has paused enrollment in a Phase 1/2 study of its therapy candidate GLPG5301 after a case of Parkinsonism was observed. The Belgium-based biotech company said in its e...
08-03 03:05
This submission is supported by data from the Phase 3 MARIPOSA-2 Study featured in a Late-Breaking Presidential Symposium session at the 2023 ESMO Congress and simultaneously published in Annals of
2023-11-20 21:15
康龙化成表示,三季度收入环比增长,预计四季度环比也会提升,全年努力做到中报给的15-20%的指引,但有一定挑战。
2023-10-31 21:05